Cargando…
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
Liver fibrosis is one of the leading causes of hepatic sclerosis and hepatocellular carcinoma worldwide. However, the complex pathophysiological mechanisms of liver fibrosis are unknown, and no specific drugs are available to treat liver fibrosis. Atractylenolide III (ATL III) is a natural compound...
Autores principales: | Wang, Yan, Shi, Kun, Tu, Jiyuan, Ke, Chang, Chen, Niping, Wang, Bo, Liu, Yanju, Zhou, Zhongshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383814/ https://www.ncbi.nlm.nih.gov/pubmed/37513376 http://dx.doi.org/10.3390/molecules28145504 |
Ejemplares similares
-
Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism
por: Ke, Chang, et al.
Publicado: (2022) -
Atractylenolide III ameliorated reflux esophagitis via PI3K/AKT/NF-κB/iNOS pathway in rats
por: Si, Xianzhe, et al.
Publicado: (2023) -
Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization
por: Xue, Meng‐Tong, et al.
Publicado: (2022) -
Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats
por: Chang, Ting, et al.
Publicado: (2019) -
Fluvoxamine ameliorates oxidative stress and inflammation induced by bile-duct ligation in male rats
por: Barmoudeh, Zahra, et al.
Publicado: (2022)